Assessment of the impact of age on DIBH in radiotherapy based on the prospective GATTUM and B-REST trials
Based on our results age alone should not be used as a criterion for excluding patients from DIBH in the treatment of left-sided breast cancer.
Authors
- Kai Joachim Borm (ORCID: https://orcid.org/0009-0005-8580-890X)
- Sophia Kiesl
- Stephanie Elisabeth Combs (ORCID: https://orcid.org/0000-0002-6934-2864)
- Marciana Nona Duma (ORCID: https://orcid.org/0000-0002-0205-4411)
- Mathias Düsberg
- Nina A. Mayr (ORCID: https://orcid.org/0000-0003-2182-7739)
- Jana Nano (ORCID: https://orcid.org/0000-0003-4731-5491)
- Markus Oechsner (ORCID: https://orcid.org/0000-0003-1981-7021)
- R. Moser
- Maximilian Aigner
- S Behzadi
- Lena Marie Buchecker
- Jantje M Bohlen
Institutions
- German Cancer Research Center (DE)
- TUM Klinikum (DE)
- Helmholtz Zentrum München (DE)
- MSH Medical School Hamburg – University of Applied Sciences and Medical University (DE)
- Helios Hospital Schwerin (DE)
- German Marine Research Consortium (DE)
- German Centre for Cardiovascular Research (DE)
- Technical University of Munich (DE)
- Michigan State University (US)
Publication Details
- Journal
- Clinical and Translational Radiation Oncology
- Published
- 2025-04-08
- DOI
- https://doi.org/10.1016/j.ctro.2025.100956
- Primary Topic
- Advanced Radiotherapy Techniques
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Deutsche Krebshilfe